Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London
Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27, 2011 at 3:40 PM BST. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s business activities and financial [...]
In: Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, Healthcare Conference · Tagged with: Business, Chief executive officer, Emergent BioSolutions, Global Healthcare Conference
Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
ROCKVILLE, Md., — Emergent BioSolutions Inc. (NYSE:EBS) announced on June 23rdthat the Singapore Health Sciences Authority (HSA) has approved Emergent’s product license application for the marketing and sale of BioThrax(R) (Anthrax Vaccine Adsorbed) in Singapore. BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration (FDA) to protect against anthrax infection.
“Emergent is [...]
In: Biothrax, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, Healthcare, U.S. Food and Drug Administration · Tagged with: Anthrax vaccines, Biothrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Singapore Ministry of Health
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors
ROCKVILLE, Md., Jun 13, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that its Chairman and Chief Executive Officer, Fuad El-Hibri, has been appointed to serve on the Board of Directors of the U.S. Chamber of Commerce. The U.S. Chamber of Commerce is the world’s largest business federation representing the interests of more [...]
In: Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, entrepreneur · Tagged with: Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, International Biomedical Research Alliance, United States Chamber of Commerce
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]
In: Business, El-Hibri, Financial Performance, Fuad El-Hibri, Healthcare Conference, Investors · Tagged with: Business, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Management, Webcast
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine Congress
ROCKVILLE, Md., Apr 12, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been recognized as Biotech CEO of the Year during the Vaccine Industry Excellence (ViE) Awards at the World Vaccine Congress. The ViE awards showcase excellence and honor accomplishments of both individuals [...]
In: Chief Executive Officer, El-Hibri, Emergent Bioslutions, Food and Drug Administration, Fuad El-Hibri · Tagged with: Biotech, Biotech CEO of the Year, Biotechnology, Chief executive officer, Fuad El-Hibri
Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference
Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of [...]
In: Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, Healthcare Conference · Tagged with: Business, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Needham & Company Healthcare Conference
Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10, 2011
ROCKVILLE, Md., Feb 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today it will report financial results for the fourth quarter and full year 2010 on Thursday, March 10, 2011, after market close.
Company management will host a conference call at 5:00 pm Eastern on March 10, 2011 to discuss [...]
In: Chief Executive Officer, El-Hibri, Emergent Bioslutions, Food and Drug Administration, Fuad El-Hibri · Tagged with: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Emergent BioSolutions, Infectious disease, Pharmaceuticals
CEO took roundabout path to Emergent
By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]
In: Chief Executive Officer, El-Hibri, Emergent Bioslutions, Food and Drug Administration, Fuad El-Hibri, U.S. Food and Drug Administration, United States, Yale university · Tagged with: Chief executive officer, DEPARTMENT OF HEALTH AND HUMAN SERVICES, El-Hibri, Emergent Biosolutions Inc, entrepreneur, Rockville
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion’s Seattle headquarters on October 28, 2010. The acquisition [...]
In: Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri, Seattle, Trubion Pharmaceuticals, United States · Tagged with: Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Seattle, Trubion Pharmaceuticals
Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010
ROCKVILLE, Md., Oct 13, 2010 — Emergent BioSolutions Inc. (NYSE: EBS) announced today it will report financial results for third quarter 2010 on Thursday November 4, 2010, after market close. Company management will host a conference call at 5:00 pm Eastern on November 4, 2010 to discuss the financial results for [...]
In: Anthrax vaccines, Business, Chief Executive Officer, Emergent Bioslutions, Fuad El-Hibri · Tagged with: Anthrax vaccines, Chief executive officer, Conference call, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri